Cargando…

Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms

Detalles Bibliográficos
Autores principales:	Sun, Yao, Wang, Lei, Feng, Rui, Wang, Nan, Wang, Yuxi, Zhu, Dandan, Xing, Xiaorui, Yang, Peng, Zhang, Yanjun, Li, Weimin, Wang, Xiangxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005859/ https://www.ncbi.nlm.nih.gov/pubmed/33782529 http://dx.doi.org/10.1038/s41422-021-00497-7

Ejemplares similares

Structure-based development of human antibody cocktails against SARS-CoV-2
por: Wang, Nan, et al.
Publicado: (2020)

Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection
por: Yao, Hangping, et al.
Publicado: (2020)

Antibody cocktail effective against variants of SARS-CoV-2
por: Liang, Kang-Hao, et al.
Publicado: (2021)

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
por: Qu, Yuanyuan, et al.
Publicado: (2021)

An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2
por: Sun, Chunyun, et al.
Publicado: (2022)

Potent neutralizing RBD‐specific antibody cocktail against SARS‐CoV‐2 and its mutant
por: Jia, Lina, et al.
Publicado: (2021)

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Ku, Zhiqiang, et al.
Publicado: (2021)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
por: Cao, Yunlong, et al.
Publicado: (2022)

Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes
por: Wang, Shuren, et al.
Publicado: (2022)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
por: Ji, Yun, et al.
Publicado: (2022)

Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktails
por: Ma, Hang, et al.
Publicado: (2023)

The architecture of the SARS-CoV-2 RNA genome inside virion
por: Cao, Changchang, et al.
Publicado: (2021)

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
por: Baum, Alina, et al.
Publicado: (2020)

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
por: Hansen, Johanna, et al.
Publicado: (2020)

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
por: Dong, Jinhui, et al.
Publicado: (2021)

Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Ku, Zhiqiang, et al.
Publicado: (2021)

Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
por: Zhang, Chao, et al.
Publicado: (2021)

Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein
por: Tai, Linhua, et al.
Publicado: (2021)

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
por: Du, Shuo, et al.
Publicado: (2021)

Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

Speed and need: twin development challenges in rapid response for a SARS-CoV-2 antibody cocktail
por: Lehman, Aimee, et al.
Publicado: (2022)

High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV
por: Sasaki, Hiroaki, et al.
Publicado: (2022)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

REGN-COV2 antibody cocktail in patients with SARS-CoV-2: Observational study from a single institution in Japan
por: Sakurai, Ayana, et al.
Publicado: (2022)

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
por: Weinreich, David M., et al.
Publicado: (2020)

Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
por: Wan, Jinkai, et al.
Publicado: (2020)

Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
por: Palomba, Emanuele, et al.
Publicado: (2021)

Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component
por: Jugler, Collin, et al.
Publicado: (2022)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
por: Parzych, Elizabeth M., et al.
Publicado: (2022)

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
por: Du, Shuo, et al.
Publicado: (2020)

Comparison of Four Systems for SARS-CoV-2 Antibody at Three Time Points after SARS-CoV-2 Vaccination
por: Seo, Jong Do, et al.
Publicado: (2022)

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2
por: Zhang, Li, et al.
Publicado: (2021)

A novel plant‐made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS‐CoV‐2 Omicron variant
por: Jugler, Collin, et al.
Publicado: (2022)

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Un cocktail d’anticorps contre le Sars-CoV-2
por: Dalmat, Yann-Mickael
Publicado: (2022)

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection
por: Yadav, Pragya D., et al.
Publicado: (2021)

A cocktail of antibodies for COVID-19 therapy
por: Matthews, Dean B.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tk55v8o786vtk99g23djc0vsut